Your browser doesn't support javascript.
loading
Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial.
Fuchs, Charles S; Özgüroglu, Mustafa; Bang, Yung-Jue; Di Bartolomeo, Maria; Mandala, Mario; Ryu, Min-Hee; Fornaro, Lorenzo; Olesinski, Tomasz; Caglevic, Christian; Chung, Hyun C; Muro, Kei; Van Cutsem, Eric; Elme, Anneli; Thuss-Patience, Peter; Chau, Ian; Ohtsu, Atsushi; Bhagia, Pooja; Wang, Anran; Shih, Chie-Schin; Shitara, Kohei.
Afiliação
  • Fuchs CS; Yale Cancer Center and Smilow Cancer Hospital, 333 Cedar Street, New Haven, CT, 06510, USA. Charles.S.Fuchs@gmail.com.
  • Özgüroglu M; Department of Internal Medicine, Division of Medical Oncology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Bang YJ; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.
  • Di Bartolomeo M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Mandala M; Unit of Medical Oncology, University of Perugia, Perugia, Italy.
  • Ryu MH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Fornaro L; Unit of Medical Oncology, Department of Translational Research and New Technology in Medicine and Surgery, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Olesinski T; Department of Oncological Gastroenterology, Maria Sklodowska-Curie Memorial, Warsaw, Poland.
  • Caglevic C; Department of Cancer Research, Instituto Oncologico Fundacion Arturo Lopez, Santiago, Chile.
  • Chung HC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
  • Muro K; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Van Cutsem E; Department of Digestive Oncology, University Hospitals Gasthuisberg Leuven and KU, Leuven, Belgium.
  • Elme A; Chemotherapy Centre and Oncology and Hematology Clinic, The North Estonia Medical Centre, Tallinn, Estonia.
  • Thuss-Patience P; Medical Department, Division of Hematology, Oncology, and Tumor Immunology, Charité-University Medicine Berlin, Campus Virchow-Klinikum, Berlin, Germany.
  • Chau I; Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK.
  • Ohtsu A; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Bhagia P; Department of Medical Oncology, Merck & Co., Inc, Kenilworth, NJ, USA.
  • Wang A; Department of Biostatistics and Research Decision Science, Merck & Co., Inc, Kenilworth, NJ, USA.
  • Shih CS; Department of Medical Oncology, Merck & Co., Inc, Kenilworth, NJ, USA.
  • Shitara K; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Gastric Cancer ; 25(1): 197-206, 2022 01.
Article em En | MEDLINE | ID: mdl-34468869
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Paclitaxel Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Gastric Cancer Assunto da revista: GASTROENTEROLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Paclitaxel Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Gastric Cancer Assunto da revista: GASTROENTEROLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Japão